Location History:
- Schupfen, CH (2000 - 2004)
- Bern, CH (2004 - 2014)
Company Filing History:
7 out of 61 
3 out of 1,248 
1 out of 17 
Years Active: 2000-2014
Title: The Innovations of Joachim Frey
Introduction
Joachim Frey is a notable inventor based in Bern, Switzerland. He has made significant contributions to the field of biotechnology, particularly in the area of protein toxins. With a total of 11 patents to his name, Frey's work has had a considerable impact on scientific research and medical applications.
Latest Patents
Among his latest patents, Frey has developed a novel secreted toxin known as CctA. This toxin exhibits strong hemolytic activity towards erythrocytes of various species. His research indicates that anti-CctA antibodies can fully neutralize hemolysis on standard blood-agar medium or in cell-free supernatants of liquid cultures. Another significant invention is the protein toxin named exoenzyme T (AexT), which belongs to the family of ADP-ribosylating toxins. This invention includes diagnostic, preventive, and therapeutic techniques, such as the preparation of bacterin vaccines based on AexT for inducing immunity against infections.
Career Highlights
Frey has worked with prestigious institutions, including the University of Bern and Akzo Nobel N.V. His research has been pivotal in advancing our understanding of protein toxins and their applications in medicine.
Collaborations
Throughout his career, Frey has collaborated with notable colleagues such as Michael A. Kuzyk and Jan Burian. These partnerships have further enriched his research and innovations.
Conclusion
Joachim Frey is a distinguished inventor whose work in biotechnology continues to influence the field significantly. His patents and collaborations reflect his commitment to advancing scientific knowledge and medical solutions.